Clinical trial · Interventional
Impact of Acceptance and Commitment Therapy on Early Stage Breast Cancer
Impact of Acceptance and Commitment Therapy on Salivary Cortisol in Breast Cancer
NCT01164930CI-TRIAL-00054235ACTcompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this randomized controlled trial is to evaluate the effectiveness of an empirically supported psychosocial treatment, Acceptance and Commitment Therapy, in facilitating improved quality of life, benefit-finding, and cortisol rhythm in breast cancer patients in an outpatient clinical oncology setting.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Neoplasms | Breast Neoplasm | ONTOLOGY_EXACT | 0.98 |
| Stress | — | UNRESOLVED | — |
| Survivorship | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Acceptance and Commitment Therapy | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Acceptance and Commitment Therapy group
- description
- 8-week ACT group
- interventionNames
- Behavioral: Acceptance and Commitment Therapy
- type
- NO_INTERVENTION
- label
- Wait-list control group
- description
- Participants will be offered treatment following wait-list data collection
Primary outcomes (1)
- measure
- salivary cortisol
- timeFrame
- 3-month follow-up
Secondary outcomes (3)
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * diagnosis of stage I-III breast cancer * prescreen distress score above defined cutoff * agreement not to seek other breast cancer support services until study completion Exclusion Criteria: * previous cancer * prior psychiatric treatment for serious mental health disorder (e.g., hospitalization or formal diagnosis of psychosis, major depressive episode, borderline mental retardation, suicidality, or current substance dependence) * current use of medications known to interfere with cortisol levels (e.g., dexamethasone) * major concurrent medical disease
References
Publications (0)
Data not yet available
No reference posted for this study.